Deciphering the Role of the Coronavirus Macro Domain in SARS-CoV Infection

破译冠状病毒宏结构域在 SARS-CoV 感染中的作用

基本信息

  • 批准号:
    8781200
  • 负责人:
  • 金额:
    $ 5.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-12-25 至 2015-12-24
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of the applicant is to be a successful independent scientist with a research program that focuses on virus-host interactions at the molecular level using tissue culture and mouse models of infection, with a particular interest in uncovering functions of viral proteins. Coronaviruses cause a variety of diseases in mammalian species. They have the potential to cause significant human morbidity and mortality as highlighted by the emergence of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and more recently the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). All Coronaviruses encode a highly conserved Macro domain within non-structural protein (nsp) 3 that makes it a useful therapeutic target. Macro domains are ADP-ribose (ADR) binding molecules conserved in eukaryotes and have diverse functions. The coronavirus Macro domain has phosphatase activity that converts ADP- ribose-1"-phosphate (ADRP) into ADP-ribose (ADR). However, the role of this activity in viral replication or pathogenesis has remained a mystery. Using a mouse-adapted SARS-CoV (MA15), a Macro domain mutant virus was engineered and shown to replicate in tissue culture cells with wild-type kinetics. However, it is completely unable to cause lethal pneumonia in BALB/c mice and induces a large increase in specific pro-inflammatory cytokines compared to wild-type virus. The overall goal of this project is to determine the role for the Macro domain during SARS-CoV and other Coronavirus infections and determine why these viruses universally encode for this protein. Aim 1. We will identify the complete spectrum of cytokines that are differentially regulated during wild type and mutant virus infection using a broad range of methods including microarrays, qRT-PCR, and ELISAs. Active site Macro domain mutants in Murine Hepatitis Virus (MHV, a mouse model for coronavirus biology) and MERS-CoV will be engineered and used to expand our analyses to multiple cell types and coronavirus infection models. Aim 2. To identify the basis of upregulation of pro-inflammatory cytokines in cells infected with mutant virus, individual steps in their activation pathways will be analyzed. Additionally, purified ADRP will be used to test the intriguing possibility that ADRP may be a novel pathogen-associated molecular pattern (PAMP) that activates an innate immune response. Following completion of training, the applicant will be versed in tools needed to study the genetics, molecular biology, and pathogenesis of coronaviruses.
描述(由申请人提供):申请人的长期目标是成为一名成功的独立科学家,拥有一项研究计划,重点是使用组织培养和小鼠感染模型在分子水平上研究病毒与宿主的相互作用,并对揭示病毒蛋白质的功能特别感兴趣。冠状病毒在哺乳动物物种中引起多种疾病。它们有可能造成严重的人类发病率和死亡率,严重急性呼吸综合征冠状病毒(SARS-CoV)和最近的中东呼吸综合征冠状病毒(MERS-CoV)的出现就突显了这一点。所有冠状病毒都在非结构蛋白(NSP)3中编码一个高度保守的宏结构域,这使其成为有用的治疗靶点。大分子结构域是真核生物中保守的ADP-核糖(ADR)结合分子,具有多种功能。冠状病毒大分子结构域具有将ADP-核糖-1“-磷酸(ADRP)转化为ADP-核糖(ADR)的磷酸酶活性。然而,这种活性在病毒复制或发病机制中的作用仍然是一个谜。利用小鼠适应的SARS冠状病毒(MA15),设计了一种大结构域突变病毒,并证明其在组织培养细胞中以野生型动力学方式复制。然而,与野生型病毒相比,它完全不能引起BALB/c小鼠致死性肺炎,并诱导特异性促炎细胞因子大量增加。该项目的总体目标是确定宏结构域在SARS-CoV和其他冠状病毒感染中的作用,并确定为什么这些病毒普遍编码这种蛋白质。目的1.我们将利用基因芯片、qRT-PCR和ELISA等多种方法鉴定野生型和变异型病毒感染过程中差异调控的细胞因子的全谱。小鼠肝炎病毒(MHV,一种冠状病毒生物学的小鼠模型)和MERS-CoV中的活性部位宏区突变将被设计并用于将我们的分析扩展到多种细胞类型和冠状病毒感染模型。目的2.为了确定在感染变异病毒的细胞中促炎细胞因子上调的基础,我们将分析其激活途径中的各个步骤。此外,纯化的adrp将被用来测试adrp可能是一种新的病原体相关分子模式(PAMP)的有趣的可能性,它可以激活先天性免疫反应。完成培训后,申请者将精通研究冠状病毒的遗传学、分子生物学和发病机制所需的工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony R Fehr其他文献

Anthony R Fehr的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony R Fehr', 18)}}的其他基金

Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
  • 批准号:
    10386112
  • 财政年份:
    2020
  • 资助金额:
    $ 5.33万
  • 项目类别:
Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
  • 批准号:
    10027966
  • 财政年份:
    2020
  • 资助金额:
    $ 5.33万
  • 项目类别:
Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
  • 批准号:
    10256655
  • 财政年份:
    2020
  • 资助金额:
    $ 5.33万
  • 项目类别:
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus Infection
研究 ADP-核糖基化如何影响冠状病毒感染期间的先天免疫
  • 批准号:
    9428897
  • 财政年份:
    2018
  • 资助金额:
    $ 5.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了